Emefcy will be presenting at 121 Hong Kong Tech Investment 15 - 16 June 2017.
http://www.weare121.com/121techinvestment-hk/clients/emefcy-2/
Link to management interview:
http://www.weare121.com/121techinvestment-hk/emefcy-management-interview/
Sum up your company for us in a sentence or two.
Emefcy Group offers a commercially proven wastewater treatment solution that is aimed at disrupting the existing markets and economics of wastewater treatment whilst addressing the global need for clean water. Its first product family, SABRE – is a capital-efficient, modular and decentralised solution that delivers superior performance while using 90% less energy compared to conventional state of the art solutions. This energy efficiency translates to a 50% reduction in OPEX of a plant using state of the art alternative.
Tell us a little about you and your team’s background and any career highlights so far.
Richard Irving – Executive Chairman Co-founder of Pond Venture Partners with 30+ years experience in venture capital, business management, marketing and engineering. Involved with 30+ start-ups and has participated in US$3bn+ of IPOs, M&A and private financings.
Eytan Levy – Founder & CEO
25+ years of technical experience and is recognised as one of Israel’s leading water entrepeneurs. Previously, alongside Ronen Schechter, co-founder of AqWise and led its successful entry to market and commercialisation. AqWise is now a leader in biological wastewater treatment with 350+ installations in 30 countries.
Ross Haghighat – Director
25+ years experience in the field of innovation and strategic reform, with numerous hands-on roles helping entrepreneurs and companies mature from startup to globally embraced operations, with 2 billion dollar plus exits and the creation of $4bn+ of shareholder value.
Peter Marks – Director
30+ years experience in corporate finance, specialising in capital raising, underwriting IPOs and VC transactions.
Robert Wale – Director
30+ years experience in the global water industry across multiple stages of a business’s growth cycle and multiple responsibilities including strategy, business, sales, marketing and operations.
Ronen Schechter – CTO
Credited as one of Israel’s leading water technology executives, with 17+ years experience in water technology R&D. Previously co-founder of AqWise, alongside Eytan Levy
What is the focus of your management team in 2016/17? What are the key milestones you are looking to reach over the next year that you think will add value to the business?
Emefcy’s focus in 2016 is concentrated on three primary work streams:
a) Transitioning the pipeline of projects to closed contracts. We are targeting those projects with a high-priority and short term need; e.g. needing a solution in place before year end.
b) Development of our Chinese market strategy. We are very excited about the opportunity within China, which we believe to be a significant opportunity, driven by the identified need for >100,000 decentralised wastewater treatment plants in the 13th 5Year Plant, wherein our product solution is relevant to 30,000+ such projects. At an average estimated project cost of 4M RMB per project, this represents an addressable market of 120 billion RMB. We are pursuing a range of partnership options and are evaluating several business models in order to best take advantage of this opportunity.
c) Development of our water as a service revenue model. We believe that EMC has an opportunity to prosper even further with a recurring, annuity style revenue model, selling wastewater treatment and recycled water as a service. Our current estimates that such a recurring revenue model would delivery multiple times the profit over a 10 year period compared to product sales. Such a model would make EMC a junior utility player with annuity style take or pay contracts with our clients.
What do you see as the key risks and challenges facing your company at the moment and how are you overcoming these?
The wastewater industry is inherently risk-adverse and often requires the demonstration of a consistent and reliable track record before adopting new technologies. Establishing reference sites in local regions will provide better exposure to Emecfy Group’s products to potential customers in those regions.
The greatest challenge is the uncontrollable factor of when a contract closes and permits are granted. To manage this risk, we are continually reprioritising opportunities in the pipeline around those which can be quickly closed, implemented and advanced in line with our strategic goals.
What is your main aim in coming to the 121 Tech Investment conference? Who do you hope to meet?
Considering the fact that our China strategy will drive substantial future shareholder value for our company, we seek to introduce EMC to the China-focused investor community.
Investors like to see that management have “skin in the game”. Tell us briefly about your management team’s investment in the business.
Richard Irving’s Plan B Ventures hold:[21M]
Ronen Schechter:[6M]
Eytan Levy holds: [9M]
In a sentence, what do you think makes your company such a compelling investment?
Emefcy has the potential to significantly disrupt an $8bn directly addressable market with commercially proven products and a strong pipeline of projects already in place.
